How do infections contribute to CKD?

The Chronic Kidney Disease Solution™ By Shelly Manning It is an eBook that includes the most popular methods to care and manage kidney diseases by following the information provided in it. This easily readable eBook covers up various important topics like what is chronic kidney disease, how it is caused, how it can be diagnosed, tissue damages caused by chronic inflammation, how your condition is affected by gut biome, choices for powerful lifestyle and chronic kidney disease with natural tools etc.

Infections can significantly contribute to the development and progression of Chronic Kidney Disease (CKD) through various mechanisms. Here’s a detailed exploration of how infections impact CKD, supported by multiple sources:

Mechanisms of Infection-Induced CKD

Glomerulonephritis:
- Mechanism: Infections can trigger an immune response that causes inflammation in the glomeruli, the filtering units of the kidneys. This condition is known as glomerulonephritis.
- Impact: Acute glomerulonephritis can progress to chronic glomerulonephritis if not properly treated, leading to CKD. Post-streptococcal glomerulonephritis, which occurs after a streptococcal throat infection, is a common example.
- Sources: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) – Glomerulonephritis.
Pyelonephritis:
- Mechanism: Pyelonephritis is a type of urinary tract infection (UTI) that affects the kidneys. It can be acute or chronic.
- Impact: Recurrent or chronic pyelonephritis can cause scarring and permanent damage to the kidney tissue, leading to CKD. The repeated inflammation damages the renal parenchyma and impairs kidney function.
- Sources: Mayo Clinic – Pyelonephritis.
HIV-Associated Nephropathy (HIVAN):
- Mechanism: HIV infection can directly infect kidney cells, leading to HIV-associated nephropathy (HIVAN). This condition is characterized by focal segmental glomerulosclerosis (FSGS) and tubulointerstitial inflammation.
- Impact: HIVAN can rapidly progress to end-stage renal disease (ESRD) if not properly managed. Antiretroviral therapy (ART) has been shown to reduce the incidence and progression of HIVAN.
- Sources: American Journal of Kidney Diseases – HIV-Associated Nephropathy.
Hepatitis C Virus (HCV) Infection:
- Mechanism: HCV can cause glomerular diseases such as membranoproliferative glomerulonephritis (MPGN) and cryoglobulinemia, which involve immune complex deposition in the kidneys.
- Impact: HCV-associated glomerular diseases can lead to CKD. Effective antiviral treatment of HCV can reduce kidney inflammation and slow the progression of CKD.
- Sources: National Kidney Foundation – Hepatitis C and Kidney Disease.

Impact on CKD Progression

Accelerated Progression:
- Data: Infections can accelerate the progression of CKD by causing acute kidney injury (AKI) episodes that worsen underlying kidney damage. Each AKI episode can lead to further loss of kidney function, hastening the transition to ESRD.
- Sources: Clinical Journal of the American Society of Nephrology – AKI and CKD Progression.
Increased Morbidity and Mortality:
- Complications: CKD patients with concurrent infections face higher morbidity and mortality rates due to complications such as sepsis, cardiovascular events, and exacerbation of existing kidney damage.
- Sources: American Society of Nephrology – Infections and CKD.

Prevention and Management

Infection Control:
- Hygiene Practices: Emphasizing good hygiene practices, including hand washing and safe food handling, can help prevent infections that may lead to CKD.
- Vaccinations: Vaccination against hepatitis B, influenza, and pneumococcal infections can reduce the risk of infections that contribute to CKD.
- Sources: Centers for Disease Control and Prevention (CDC) – Vaccination for CKD Patients.
Early Detection and Treatment:
- Screening: Regular screening for infections in high-risk populations, including those with diabetes, hypertension, and existing CKD, can facilitate early detection and treatment.
- Antiviral Therapy: Early and effective antiviral therapy for HIV and HCV can prevent kidney damage and slow CKD progression.
- Sources: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) – Preventing Infections in CKD.

Conclusion

Infections play a significant role in the development and progression of CKD through mechanisms such as glomerulonephritis, pyelonephritis, HIVAN, and HCV-associated glomerular diseases. Preventing and effectively managing infections is crucial in reducing the burden of CKD and improving outcomes for affected individuals.

References:

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) – Glomerulonephritis
Mayo Clinic – Pyelonephritis
American Journal of Kidney Diseases – HIV-Associated Nephropathy
National Kidney Foundation – Hepatitis C and Kidney Disease
Clinical Journal of the American Society of Nephrology – AKI and CKD Progression
American Society of Nephrology – Infections and CKD
Centers for Disease Control and Prevention (CDC) – Vaccination for CKD Patients